Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $70.00 at HC Wainwright
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) had its price objective hoisted by investment analysts at HC Wainwright from $69.00 to $70.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 31.53% from the company’s previous close. […]
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) had its price objective hoisted by investment analysts at HC Wainwright from $69.00 to $70.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 31.53% from the company’s previous close. […]
